1. Home
  2. HIHO vs RNAZ Comparison

HIHO vs RNAZ Comparison

Compare HIHO & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIHO
  • RNAZ
  • Stock Information
  • Founded
  • HIHO 1990
  • RNAZ 2016
  • Country
  • HIHO Hong Kong
  • RNAZ United States
  • Employees
  • HIHO N/A
  • RNAZ N/A
  • Industry
  • HIHO Industrial Machinery/Components
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIHO Industrials
  • RNAZ Health Care
  • Exchange
  • HIHO Nasdaq
  • RNAZ Nasdaq
  • Market Cap
  • HIHO 7.7M
  • RNAZ 8.7M
  • IPO Year
  • HIHO 1996
  • RNAZ 2021
  • Fundamental
  • Price
  • HIHO $1.44
  • RNAZ $9.16
  • Analyst Decision
  • HIHO
  • RNAZ Strong Buy
  • Analyst Count
  • HIHO 0
  • RNAZ 1
  • Target Price
  • HIHO N/A
  • RNAZ $280.00
  • AVG Volume (30 Days)
  • HIHO 7.9K
  • RNAZ 24.9K
  • Earning Date
  • HIHO 10-10-2025
  • RNAZ 11-14-2025
  • Dividend Yield
  • HIHO 8.33%
  • RNAZ N/A
  • EPS Growth
  • HIHO N/A
  • RNAZ N/A
  • EPS
  • HIHO 0.01
  • RNAZ N/A
  • Revenue
  • HIHO $7,080,000.00
  • RNAZ N/A
  • Revenue This Year
  • HIHO N/A
  • RNAZ N/A
  • Revenue Next Year
  • HIHO N/A
  • RNAZ N/A
  • P/E Ratio
  • HIHO $148.06
  • RNAZ N/A
  • Revenue Growth
  • HIHO 3.31
  • RNAZ N/A
  • 52 Week Low
  • HIHO $1.40
  • RNAZ $6.15
  • 52 Week High
  • HIHO $2.08
  • RNAZ $468.44
  • Technical
  • Relative Strength Index (RSI)
  • HIHO 25.71
  • RNAZ 31.84
  • Support Level
  • HIHO $1.43
  • RNAZ $8.90
  • Resistance Level
  • HIHO $1.65
  • RNAZ $9.85
  • Average True Range (ATR)
  • HIHO 0.05
  • RNAZ 0.79
  • MACD
  • HIHO -0.01
  • RNAZ -0.43
  • Stochastic Oscillator
  • HIHO 4.55
  • RNAZ 5.81

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: